Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
about
Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor familyStructural and functional studies on platelet-derived growth factorCloning and characterization of a human type II receptor for bone morphogenetic proteinsRole of platelet-derived growth factors in physiology and medicineMolecular genetics of neurological tumoursAngiogenic growth factors in neural embryogenesis and neoplasiaMulticentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastomaGrowth factors outside the PDGF family drive experimental PVR.Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential.Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomasRole of receptor tyrosine kinases and their ligands in glioblastoma.Angiogenesis inhibitors: current strategies and future prospects.Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance.RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.Targeting the PDGF signaling pathway in tumor treatmentEarly inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivoNG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.Platelet-derived growth factor alpha receptor gene expression: isolation and characterization of the promoter and upstream regulatory elementsGenomic aberrations in pediatric diffuse intrinsic pontine gliomasHeparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant gliomaHypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.Expression of growth factor receptors in human brain tumours.Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumoursRequirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.Novel therapeutic targets in the brain tumor microenvironmentPrevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model.Platelet-derived growth factor receptor alpha in glioma: a bad seedPhosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation.The role of PDGF in radiation oncology.Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.
P2860
Q28575999-A62F234F-D7BE-4B5A-BDEA-FE43F0029F83Q54973499-35042F2B-C071-4B70-8B52-E3318F1962CAQ54973503-FDDE93F0-4B35-42A6-86BC-C093F43D1BC1Q54973507-E42FD48F-54FE-4D10-A5F1-52E86A37C290Q54973509-9B4E1E97-4DCF-4CE5-AE2F-0563181F1319Q54973510-33A52A30-BF16-48FA-91C8-0F8E995F0C62Q54973513-7D9C0694-CC2B-4021-9CC3-6298D1D8BA73Q54973519-36BF9270-3944-482A-B368-951276C7D3F5Q54973520-16390A63-80D7-41E5-9385-D86F194266A7Q54973553-BC9A9CE5-964C-4925-868F-1BE34807A459Q54973555-8650CCDA-0353-4BA5-8093-9608AF0901C1Q54973568-D2890415-F4B0-44A0-BA38-3A6BA79CE19EQ54973572-A256FFCF-7078-467F-B5C3-CF49A78575A3Q54973574-C7604B52-EC47-4A05-B1B7-331B6A7A8542Q54973576-16FCE14D-2A37-402A-B324-95FD1A738B9DQ54973577-DD637D5A-44D9-4311-A01C-8D816A6FE87EQ54973579-F532A012-1510-4E2A-BEDC-8101A492749EQ54973590-1EA89A38-22C2-417F-98E6-EF0FE29E76DFQ54973592-5A392398-59BD-4076-871C-BAC754F0FEF6Q54973594-8721BF0B-BB09-4796-BEF3-1E5A08A409F7Q54973599-894833A0-DC6B-47E5-91F9-16FD59C8561E
P1343
Q24319040-C717D8A3-FEED-41DC-99A4-108DF56216F0Q24555662-BA3EFAC2-C743-4C5F-A88F-870D923CB55FQ24561622-FEC205D9-9701-438A-B52A-72B5A9E23A95Q29615222-052EB6D3-5765-4065-BD40-784595DBBDD9Q30495393-ACCD98CD-F094-445C-89D6-D7BA624D5891Q30498863-7FED9893-4915-4BE4-9777-1D90233B49E5Q33387009-289D0AAD-3F7F-44C7-A3B9-CAF61D0E0BEEQ33557530-CB03860D-122C-4991-B197-52CB999492FCQ33609232-50B73DD2-470B-4E98-9560-4B5E65855231Q33656940-BDD89E89-2632-4B0D-995F-6F3C7EB44EE2Q33715843-3FBF57AD-53AC-4D59-9536-5B1DD7E358FFQ33780536-67006CB3-D1F7-43F2-8122-5A50D7357D62Q33881165-C1519BDF-2B3A-44E7-A44C-92D3F476A6C0Q33883849-A64C6F41-CF23-4F9F-ADDE-28612109FCD0Q34056376-28A52C2A-1676-4E28-8510-2463A4723FE6Q34255631-FA07B26B-F076-4823-9AB0-FDA383CFA721Q34308033-30F7F49E-BB3A-4B9E-BEB9-B0DF14976044Q34393461-DD6EE22F-2966-48D8-95CA-684A93D55878Q34509145-F7475208-B8EC-491E-A8C5-68C116B2F3EBQ34539833-77762ADA-19F7-4EF9-B633-8C76315B237AQ34768422-D36E3295-89A0-4B84-9131-B2E0FD59832EQ35000404-6FD1A8AC-0B55-4828-BF43-DD69ED690158Q35080265-F9A7D1E4-C5D2-464B-A346-0BC7A799C98EQ35133431-3AA79E3F-1114-4A20-831D-84B5034E1D72Q35613078-AEC506C7-AB28-4E5D-9292-3960416627BFQ35760625-55487D73-7A23-4BC6-886F-A673D6274D2DQ35780214-12632F99-C4AD-4EB1-AF6E-C427FA59106AQ35800467-09AB2E13-DC5E-4EAC-B02C-E545FFF738AEQ35832427-B4EE5A10-6867-4F8E-B168-244C52F1ED3EQ35975667-148030D8-99FF-4C75-B5DC-71D454D01E6AQ35982942-4CE3A59F-F505-478F-908C-F02C32C55490Q35994127-E89F52E6-BC79-464D-AE42-7824662BFB76Q36021361-93421B48-6B4C-47ED-9766-57DF187011B0Q36071884-4B3E7E5C-58E6-4EC2-BC31-78E5CB8CD109Q36344757-6BAE7B0E-422F-427E-934E-99E8F10C8C46Q36520705-C6C85667-60AD-4BEA-A605-ACC751448EA6Q36528159-81418FDF-8C09-4D8C-9227-34329C82F421Q36564274-65BE4EC1-30E2-4D43-BFA3-5737D263D85EQ36705396-B6D9B7FD-3F6B-420F-9D33-EEC9B095E1FBQ36745372-896BC808-535F-4C81-B0A3-E5717AB95FBE
P2860
Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@en
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@nl
type
label
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@en
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@nl
prefLabel
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@en
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@nl
P2093
P4510
P1433
P1476
Expression of messenger RNAs f ...... n malignant glioma cell lines.
@en
P2093
Claesson-Welsh L
Libermann TA
Pettersson M
Schlessinger J
P304
P407
P577
1988-07-01T00:00:00Z